Healthcare provider profile · identity verified

Mandana Emami, M.D.

Internal Medicine · DUBLIN, OH · NPI 1962437483

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	608	172
Amlodipine Besylate	Amlodipine Besylate	421	115
Levothyroxine Sodium	Levothyroxine Sodium	322	83
Atorvastatin Calcium	Atorvastatin Calcium	252	70
Losartan Potassium	Losartan Potassium	248	66
Omeprazole	Omeprazole	209	64
Lisinopril	Lisinopril	200	55
Pantoprazole Sodium	Pantoprazole Sodium	160	37
Gabapentin	Gabapentin	148	38
Hydrochlorothiazide	Hydrochlorothiazide	133	37
Metoprolol Succinate	Metoprolol Succinate	133	35
Metformin Hcl	Metformin Hcl	129	34
Simvastatin	Simvastatin	127	33
Sertraline Hcl	Sertraline Hcl	116	31
Metformin Hcl Er	Metformin Hcl	113	32
Albuterol Sulfate Hfa	Albuterol Sulfate	106	36
Trazodone Hcl	Trazodone Hcl	100	21
Escitalopram Oxalate	Escitalopram Oxalate	93	26
Carvedilol	Carvedilol	90	21
Metoprolol Tartrate	Metoprolol Tartrate	89	26
Jardiance	Empagliflozin	82	15
Duloxetine Hcl	Duloxetine Hcl	79	16
Bupropion Xl	Bupropion Hcl	78	19
Furosemide	Furosemide	78	25
Lorazepam	Lorazepam	68	13
Synthroid	Levothyroxine Sodium	67	18
Tramadol Hcl	Tramadol Hcl	60	18
Valsartan	Valsartan	60	14
Montelukast Sodium	Montelukast Sodium	59	16
Ozempic	Semaglutide	59	14
Tamsulosin Hcl	Tamsulosin Hcl	59	17
Potassium Chloride	Potassium Chloride	56	13
Azithromycin	Azithromycin	55	39
Fluticasone Propionate	Fluticasone Propionate	53	21
Clopidogrel	Clopidogrel Bisulfate	52	11
Eliquis	Apixaban	52	16
Famotidine	Famotidine	52	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	suppressed
Tresiba Flextouch U-100	Insulin Degludec	48	suppressed
Ibandronate Sodium	Ibandronate Sodium	47	17
Mirtazapine	Mirtazapine	47	11
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	45	15
Citalopram Hbr	Citalopram Hydrobromide	44	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Alprazolam	Alprazolam	41	11
Hydralazine Hcl	Hydralazine Hcl	40	11
Finasteride	Finasteride	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Allopurinol	Allopurinol	31	12
Esomeprazole Magnesium	Esomeprazole Magnesium	31	11
Ezetimibe	Ezetimibe	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Prednisone	Prednisone	29	19
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	20
Atenolol	Atenolol	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Ramipril	Ramipril	24	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Methylprednisolone	Methylprednisolone	22	21
Trulicity	Dulaglutide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Spironolactone	Spironolactone	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Ciclopirox	Ciclopirox	18	13
Pregabalin	Pregabalin	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Fluconazole	Fluconazole	15	12
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Estradiol	Estradiol	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error